Browse by author
Lookup NU author(s): Dr Jennifer Court, Dr Margaret Piggott, Mary Johnson, Professor John O'Brien, Emeritus Professor Robert Perry, Dr Evelyn Jaros, Emeritus Professor Elaine Perry
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Patients with dementia with Lewy bodies (DLB) commonly experience psychotic symptoms, most notably visual hallucinations. Previously, it has been shown that visual hallucinations in DLB are associated with reduced cortical choline acetyltransferase activity, a marker of cholinergic innervation, but not with predominantly postsynaptic muscarinic M1 receptor binding. In the present investigation, nicotinic acetylcholine receptor (nAChR) levels in the temporal cortex (Brodmann's areas [BA] 20 and 36) were measured in a group of 24 prospectively assessed DLB patients; comparisons were made between groups with or without visual and auditory hallucinations and delusional misidentification. Visual hallucinations and delusional misidentification were associated with lower [125I]αbungarotoxin binding in areas 36 and 20 (P<.05), but not with changes in [3H]epibatidine binding. There were no significant associations with auditory hallucinations. [3H]epibatidine, but not [125I]αbungarotoxin, binding for all DLB cases was reduced compared to controls (P<.001). Loss of cortical α7 nicotinic receptors may contribute to hallucinations and delusional misidentification in DLB, with implications for treatment and understanding the mechanisms of psychotic symptoms in dementia. © 2001 Elsevier Science Inc. All rights reserved.
Author(s): Piggott MA; Perry RH; Perry EK; O'Brien JT; Johnson M; Court JA; Jaros E; Ballard CG; Holmes C; Cairns N; Lantos P
Publication type: Article
Publication status: Published
Journal: Pharmacology Biochemistry and Behavior
Year: 2001
Volume: 70
Issue: 4
Pages: 571-579
Print publication date: 01/01/2001
ISSN (print): 0091-3057
ISSN (electronic): 1873-5177
Publisher: Elsevier
URL: http://dx.doi.org/10.1016/S0091-3057(01)00644-X
DOI: 10.1016/S0091-3057(01)00644-X
PubMed id: 11796155
Altmetrics provided by Altmetric